Lessons learned from operating a pre-commercialisation field-testing platform for innovative non-sewered sanitation in Durban, South Africa

The Engineering Field Testing Platform (EFTP) was designed to provide an opportunity for technology  developers (TDs) to test non-sewered sanitation prototypes in the eThekwini Municipal Area (Durban), South Africa. Between 2017 and 2020, 15 sanitation systems were tested in informal settlements, peri-urban households, and other ‘real world’ settings. This paper illustrates the lessons learned from establishing and managing this testing platform. Costs and timelines for testing are dependent on several factors, including the aims of testing, the development stage of the prototype, whether testing takes place in a community or household setting and if a testing site is shared between prototypes. Timelines were routinely underestimated, particularly for community engagement and commissioning of prototypes to reach steady-state operation. Personnel accounted for more than half of the EFTP’s costs. The presence of the municipality as a platform partner was vital to the success of testing, both for gaining political support and for enabling access to testing sites. It is noted that working in communities, with test sites in public spaces, requires technical and social sensitivity to context. It was important to ensure testing supported future municipal decision-making on service provision, as well as longer-term development within communities. The high number of stakeholders, locally and internationally, raised management challenges common to any large project. However, the EFTP added value to TDs, the eThekwini Municipality, and communities requiring improved sanitation services; this was amplified through the platform approach

Androgen deprivation in prostate cancer : benefits of home-based resistance training

Introduction: Androgen deprivation therapy (ADT) has detrimental effects on body composition, metabolic health, physical functioning, bone mineral density (BMD) and health-related quality of life (HRQOL) in men with prostate cancer. We investigated whether a 12-month home-based progressive resistance training (PRT) programme, instituted at the start of ADT, could prevent these adverse effects. Methods: Twenty-five patients scheduled to receive at least 12 months of ADT were randomly assigned to either usual care (UC) (n = 12) or PRT (n = 13) starting immediately after their first ADT injection. Body composition, body cell mass (BCM; a functional component of lean body mass), BMD, physical function, insulin sensitivity and HRQOL were measured at 6 weeks and 6 and 12 months. Data were analysed by a linear mixed model. Results: ADT had a negative impact on body composition, BMD, physical function, glucose metabolism and HRQOL. At 12 months, the PRT group had greater reductions in BCM by − 1.9 ± 0.8 % (p = 0.02) and higher gains in fat mass by 3.1 ± 1.0 % (p = 0.002), compared to the UC group. HRQOL domains were maintained or improved in the PRT versus UC group at 6 weeks (general health, p = 0.04), 6 months (vitality, p = 0.02; social functioning, p = 0.03) and 12 months (mental health, p = 0.01; vitality, p = 0.02). A significant increase in the Matsuda Index in the PRT versus UC group was noted at 6 weeks (p = 0.009) but this difference was not maintained at subsequent timepoints. Between-group differences favouring the PRT group were also noted for physical activity levels (step count) (p = 0.02). No differences in measures of BMD or physical function were detected at any time point. Conclusion: A home-based PRT programme instituted at the start of ADT may counteract detrimental changes in body composition, improve physical activity and mental health over 12 months. Trial registration: Australian and New Zealand Clinical Trials Registry, ACTRN1261600131144

Liver Enzyme Abnormalities and Associated Risk Factors in HIV Patients on Efavirenz-Based HAART with or without Tuberculosis Co-Infection in Tanzania.

To investigate the timing, incidence, clinical presentation, pharmacokinetics and pharmacogenetic predictors for antiretroviral and anti-tuberculosis drug induced liver injury (DILI) in HIV patients with or without TB co-infection. A total of 473 treatment naïve HIV patients (253 HIV only and 220 with HIV-TB co-infection) were enrolled prospectively. Plasma efavirenz concentration and CYP2B6*6, CYP3A5*3, *6 and *7, ABCB1 3435C/T and SLCO1B1 genotypes were determined. Demographic, clinical and laboratory data were collected at baseline and up to 48 weeks of antiretroviral therapy. DILI case definition was according to Council for International Organizations of Medical Sciences (CIOMS). Incidence of DILI and identification of predictors was evaluated using Cox Proportional Hazards Model. The overall incidence of DILI was 7.8% (8.3 per 1000 person-week), being non-significantly higher among patients receiving concomitant anti-TB and HAART (10.0%, 10.7 per 1000 person-week) than those receiving HAART alone (5.9%, 6.3 per 1000 person-week). Frequency of CYP2B6*6 allele (p = 0.03) and CYP2B6*6/*6 genotype (p = 0.06) was significantly higher in patients with DILI than those without. Multivariate cox regression model indicated that CYP2B6*6/*6 genotype and anti-HCV IgG antibody positive as significant predictors of DILI. Median time to DILI was 2 weeks after HAART initiation and no DILI onset was observed after 12 weeks. No severe DILI was seen and the gain in CD4 was similar in patients with or without DILI. Antiretroviral and anti-tuberculosis DILI does occur in our setting, presenting early following HAART initiation. DILI seen is mild, transient and may not require treatment interruption. There is good tolerance to HAART and anti-TB with similar immunological outcomes. Genetic make-up mainly CYP2B6 genotype influences the development of efavirenz based HAART liver injury in Tanzanians

The 1.28 GHz MeerKAT DEEP2 Image

We present the confusion-limited 1.28 GHz MeerKAT DEEP2 image covering one qb » ¢ 68 FWHM primarybeam area with θ = 7 6 FWHM resolution and s = m - n 0.55 0.01 Jy beam 1 rms noise. Its J2000 center position α = 04h 13m 26 4, δ = −80° 00′ 00″ was selected to minimize artifacts caused by bright sources. We introduce the new 64-element MeerKAT array and describe commissioning observations to measure the primary-beam attenuation pattern, estimate telescope pointing errors, and pinpoint (u, v) coordinate errors caused by offsets in frequency or time. We constructed a 1.4 GHz differential source count by combining a power-law count fit to the DEEP2 confusion P(D) distribution from 0.25 to 10 μJy with counts of individual DEEP2 sources between 10 μJy and 2.5 mJy. Most sources fainter than S ∼ 100 μJy are distant star-forming galaxies (SFGs) obeying the far-IR/ radio correlation, and sources stronger than 0.25 μJy account for ∼93% of the radio background produced by SFGs. For the first time, the DEEP2 source count has reached the depth needed to reveal the majority of the star formation history of the universe. A pure luminosity evolution of the 1.4 GHz local luminosity function consistent with the Madau & Dickinson model for the evolution of SFGs based on UV and infrared data underpredicts our 1.4 GHz source count in the range -5 log Jy 4 [ ( )] S

Dichotomies of Urban Change in Durban

Urban developments the world over face a myriad of challenges. In South Africa, urban design is exacerbated by the recent implementation of democracy, which demands the dismantling of the brutal markings imprinted by apartheid planning on the South African built environment. This article investigates and compares recent developments in this changing urban fabric. The study finds its genesis in this context of transformation, which provides urban design with a unique challenge to interpret and respond to pressing urban issues peculiar to South Africa

LC-MS/MS Detection of Increased Androstenedione Levels in Patients Receiving Danazol Therapy

exterior, detail of eave with woodcarving details on a house representing an Aceh, Northern Sumatra domestic form at the park, 198

Lessons learned from operating a pre-commercialisation field-testing platform for innovative non-sewered sanitation in Durban, South Africa

The Engineering Field Testing Platform (EFTP) was designed to provide an opportunity for technology developers (TDs) to test non-sewered sanitation prototypes in the eThekwini Municipal Area (Durban), South Africa. Between 2017 and 2020, 15 sanitation systems were tested in informal settlements, peri-urban households, and other ‘real world’ settings. This paper illustrates the lessons learned from establishing and managing this testing platform. Costs and timelines for testing are dependent on several factors, including the aims of testing, the development stage of the prototype, whether testing takes place in a community or household setting and if a testing site is shared between prototypes. Timelines were routinely underestimated, particularly for community engagement and commissioning of prototypes to reach steady-state operation. Personnel accounted for more than half of the EFTP’s costs. The presence of the municipality as a platform partner was vital to the success of testing, both for gaining political support and for enabling access to testing sites. It is noted that working in communities, with test sites in public spaces, requires technical and social sensitivity to context. It was important to ensure testing supported future municipal decision-making on service provision, as well as longer-term development within communities. The high number of stakeholders, locally and internationally, raised management challenges common to any large project. However, the EFTP added value to TDs, the eThekwini Municipality, and communities requiring improved sanitation services; this was amplified through the platform approach